AAD 2026Abstract 75352
Dupilumab monotherapy improves atopic dermatitis lesions and post-inflammatory hyperpigmentation in patients with Skin of Color and moderate-to-severe atopic dermatitis
Alexis A, Markowitz O, Mayo T, Callender VD, Levit NA, Xia C, Levy S, Zahn J, Wang Z, Bosman K, Shumel B
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczemaPigmentary disordersSkin of color
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.692 · Not in PubMed: details from Crossref